Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-61.77M -61.04M -58.07M -56.07M -54.18M -53.47M -51.63M -51.88M -51.22M -50.51M -48.05M -43.74M -40.2M -33.54M -28.59M -24.45M -20.07M
Depreciation & Amortization
461.34K 556.44K 478.87K 468.21K 350.13K 352.08K 444.29K 563.21K 500.49K 511.49K 374.71K 207.75K 325.81K 159.07K 138.78K 117.09K 97.97K
Stock-Based Compensation
6.72M 6.5M 6.42M 6.26M 5.93M 5.73M 5.13M 4.72M 4.44M 4.06M 3.65M 3.22M 2.52M 1.8M 1.39M 1.06M 996.85K
Other Working Capital
1.77M -813.24K -735.21K -773.55K -1.01M 119.84K -1.99M -2.14M -1.15M -276.56K 1.17M 149.37M 149.39M 179.62M 178.35M 30.86M 29.91M
Other Non-Cash Items
149.43K 1.64M 1.37M 505.98K 535.61K -1.22M -1.12M -397.4K -717.68K -427.85K 13.11M 13.22M 13.8M 14.05M 996.65K 1.3M 669.96K
Deferred Income Tax
n/a n/a -620.19K n/a n/a n/a 620.19K n/a n/a n/a -13.51M -13.51M -13.51M -13.51M n/a n/a n/a
Change in Working Capital
855.7K -925.38K -733.53K -870.61K -1.57M -974.64K -2.38M -542.22K 213.07K 1.72M 2.29M 58.47K 440.25K 900.42K -11.66K 1.76M 527.72K
Operating Cash Flow
-53.59M -55M -52.26M -50.82M -50.04M -48.97M -48.94M -47.54M -46.24M -44.1M -41.59M -40M -36.99M -30.85M -27.07M -21.52M -18.45M
Capital Expenditures
-56.34K -84.88K -246.44K -298.32K -352.23K -342.75K -241.13K -577.12K -655.43K -742.48K -686.23K -304.44K -159.27K -60.79K -85.79K -80.05K -65.63K
Cash Acquisitions
n/a n/a -3.3M 20.61M 20.61M 20.61M -17.92M -41.34M -41.34M -41.34M 557.29K 70.35K 70.35K 70.35K n/a n/a n/a
Purchase of Investments
n/a n/a -15.75M -44.66M -44.66M -44.66M -41.29M -32.12M -42.12M -50.1M -60.59M -93.61M -83.61M -75.63M -52.76M n/a n/a
Sales Maturities Of Investments
10.5M 31.93M 45.48M 50.48M 54.73M 52.3M 53.85M 68.1M 91.18M 92.68M 72.08M 52.83M 20.5M n/a n/a n/a n/a
Other Investing Acitivies
-5.41M 16.02M 19.32M 819.24K 10.07M 7.64M 46.17M 69.59M 82.66M 76.18M 34.42M -17.85M -40.17M -52.69M -52.76M n/a n/a
Investing Cash Flow
5.03M 26.43M 24.08M 5.52M 9.72M 7.3M 12.32M 35.41M 48.4M 41.83M 10.87M -41.02M -63.19M -75.62M -52.85M -80.05K -65.63K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
220.09K 1.07M 1.11M 1.01M 29.18M 28.44M 28.25M 28.21M 65.3K 19K 211.2K 118.72M 119.67M 119.48M 119.47M 979.75K n/a
Financial Cash Flow
18.13M 5.3M 5.35M 1.01M 29.18M 28.44M 28.25M 28.21M 65.3K 19K 211.2K 118.72M 144.46M 144.26M 181.24M 62.75M 36.98M
Net Cash Flow
-30.42M -23.26M -22.83M -44.29M -11.14M -13.23M -8.38M 16.08M 2.23M -2.25M -30.51M 37.69M 44.27M 37.8M 101.33M 41.16M 18.47M
Free Cash Flow
-53.65M -55.08M -52.51M -51.12M -50.39M -49.31M -49.18M -48.11M -46.89M -44.84M -42.28M -40.31M -37.15M -30.91M -27.15M -21.6M -18.51M